Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher
Author(s) -
YennJiang Lin,
TzeFan Chao,
Hsuan-Ming Tsao,
ShihLin Chang,
LiWei Lo,
Chern-En Chiang,
YuFeng Hu,
PaiFeng Hsu,
ShaoYuan Chuang,
Cheng-Hung Li,
FaPo Chung,
YunYu Chen,
Tsu-Juey Wu,
Ming-Hsiung Hsieh,
ShihAnn Chen
Publication year - 2012
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eus336
Subject(s) - medicine , mace , atrial fibrillation , hazard ratio , catheter ablation , cardiology , ablation , stroke (engine) , proportional hazards model , confidence interval , cohort , myocardial infarction , percutaneous coronary intervention , mechanical engineering , engineering
It is not known if successful catheter ablation for atrial fibrillation (AF) improves the patient's long-term cardiovascular outcomes. This study investigated the long-term outcomes and mortality of AF patients at high risk who received antiarrhythmic medication and catheter ablation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom